Case Study: Large Pharmaceutical Company achieves unified patient and channel data for precision medicine with IntegriChain

Powering Precision Medicine with Unified Patient and Channel Data

Large Pharmaceutical Company, facing a shift from broad primary-care products to precision medicines and more complex hybrid channel strategies, struggled with late, poorly formatted channel data and limited analytical insight from its existing aggregator. To address data timeliness, quality, and visibility issues, the company engaged IntegriChain for channel data management and later for Patient Advisory Services and patient-data aggregation, seeking a solution that would integrate with its commercial data warehouse.

IntegriChain implemented end-to-end channel data solutions — including channel data aggregation, refined channel data and distribution contract management — plus Patient Data Aggregation and advisory services, and unified everything on the ICyte Platform with automated feeds into the manufacturer’s CDW. As a result, IntegriChain delivered timelier, cleaner, actionable channel and patient insights, enabling better inventory management, reduced returns allowances, elimination of stock-outs, improved DSA performance visibility, and stronger support for hybrid specialty–retail launches.